← Back to Search

Depression Screening for Depression

N/A

Recruiting

Led By Sidney Hankerson, MD, MBA

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Currently receiving formal mental health treatment

Reporting active suicidality, or verbally endorsing homicidal ideation or psychotic symptoms

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured at 3- and 6-months post-screening

Awards & highlights

No Placebo-Only Group

Summary

This trial uses Community Health Workers to screen for depression in Black churches and aims to improve treatment engagement and mental health outcomes among African American adults, who are less likely to be screened for depression in primary care settings. By using trusted community members, the study aims to encourage more people to seek treatment after screening positive for depression.

Who is the study for?

This trial is for English-speaking adults over 18 in Black church communities who may be experiencing depression, as indicated by specific questionnaire scores. It's not open to those already in formal mental health treatment or individuals with active suicidal thoughts, homicidal ideation, or psychotic symptoms.

What is being tested?

The study compares two approaches: usual referral methods versus a more involved process called SBIRT (Screening, Brief Intervention, and Referral to Treatment) conducted by Community Health Workers. The effectiveness on engaging patients with depression treatments will be measured.

What are the potential side effects?

Since this trial involves screening and referrals rather than medication or medical procedures, there are no direct side effects from interventions like you might expect with drug trials.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently in treatment for a mental health condition.

Select...

I have not had thoughts of harming myself or others, nor experienced severe mental health symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at 3- and 6-months post-screening

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at 3- and 6-months post-screening

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 3- and 6-months post-screening for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Treatment Engagement

Secondary study objectives

Change in Anxiety Severity

Change in Depressive Severity

Change in Depressive Symptoms

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SBIRTExperimental Treatment1 Intervention

SBIRT will involve screening with the Patient Health Questionnaire-9 (PHQ-9); brief intervention with Motivational Interviewing (MI); and referral to specialty treatment, as needed for subjects with persistent depressive symptoms.

Group II: Referral As UsualActive Control1 Intervention

Referral as Usual will involve distributing depression educational materials (e.g., from the National Institute of Mental Health) and contact information for treatment providers in our target community

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SBIRT

2012

Completed Phase 2

~4990

0 / 2Eligibility criteria met